2025-07-23 Drugs SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder
2025-07-20 Medical Devices SFDA Advances Healthcare Innovation Through Clinical Trials and Gene Therapy
2025-07-16 Drugs SFDA Approves Marketing Authorization for Diagnostic Medical Devices to Measure Antipsychotic Drug Levels in Blood
2025-07-14 Drugs SFDA Suspends European Pharmaceutical Factory Due to Critical Manufacturing Violations
2025-07-10 Drugs The SFDA Approves the Registration of “Winrevair” for the Treatment of Pulmonary Arterial Hypertension under the Orphan Drug Designation Pathway
2025-07-02 Medical Devices SFDA Rejects AI-Powered Diabetes Prediction Device for Failing Safety and Efficacy Standards
2025-06-30 Medical Devices SFDA Approves Marketing Authorization for Advanced Brain-Stimulation Medical Device for Parkinson's Disease
